Molecular Regulation of Hair Follicle Morphogenesis

毛囊形态发生的分子调控

基本信息

  • 批准号:
    7913746
  • 负责人:
  • 金额:
    $ 34.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-03-07 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term goal of this grant is to further our understanding of the molecular regulation of hair follicle development and cycling, with the hope that this new knowledge will provide clues to the pathogenesis of hair follicle disorders and lead to new approaches to therapy. The follicle is a powerful model for studying pathways controlling organ development and regeneration. Throughout much of adult life, follicles cycle through an active growth phase, called anagen; a regression phase, catagen; and a resting phase, telogen. Numerous factors and pathways are required for proper hair follicle development and cycling: our work has centered largely on the Hedgehog (Hh)/Gli pathway. Normally, the Hh/Gli pathway is repressed since the Hh receptor Ptch1 inhibits Smo, a key signal transducer in this pathway. Secreted Hh binds to Ptch1 and inhibits it function, relieving the inhibition of Smo, which is then free to activate signaling and ultimately modulate gene expression via Gli transcription factors. The Hh/Gli pathway has well-established functions during embryonic and postnatal hair follicle growth, where it provides a major proliferative stimulus to epithelial cells as they rapidly expand to build the mature, anagen hair follicle. However, essentially nothing is known of the role of Hh/Gli activity in a small subset of cells in the resting, telogen follicle, which was just recently discovered. In addition, the function of sustained Hh/Gli signaling in mature, anagen hair follicles is also not known. We propose to address both of these questions using several complementary in vivo approaches, which will enable us to block Hh/Gli signaling at different levels in the pathway, and at specific times during the hair cycle. We also propose to test the role of the transcriptional repressor Bmi1, a Hh/Gli target in other organs, in hair follicle biology. The results of these studies will fill in major gaps in our understanding of how Hh/Gli signaling contributes to the complex regulation of hair follicle biology, and may yield clues into the pathogenesis of hair follicle disorders. More globally, they will provide fundamental insight into pathways that are utilized by many other organs for growth and regeneration, and are commonly deregulated in cancer. Finally, since several Hh pathway inhibitors are currently in clinical trials, these studies are timely as they will lead to a better understanding of potential toxicities associated with the use of these drugs in patients. PUBLIC HEALTH RELEVANCE: Abnormalities in the hair follicle and related structures are responsible for many common skin diseases and hair loss disorders. The experiments in this grant will increase our understanding of the control mechanisms that regulate hair follicle growth and development. This knowledge should lead to new and improved treatments for hair follicle-related skin diseases.
描述(由申请人提供):这笔赠款的长期目标是进一步了解毛囊发育和骑自行车的分子调节,希望这种新知识能为毛囊疾病的发病机理提供线索,并带来新的治疗方法。卵泡是研究控制器官发育和再生的途径的强大模型。在整个成人生活的大部分时间里,卵泡循环穿越活跃的生长阶段,称为Anagen。回归阶段,catagen;和一个静止阶段,telogen。适当的毛囊发育和循环需要许多因素和途径:我们的工作主要集中在刺猬(HH)/GLI途径上。通常,由于HH受体PTCH1抑制SMO,SMO是该途径中的键信号传感器,因此HH/GLI途径被抑制。分泌的HH与PTCH1结合并抑制其功能,从而缓解了SMO的抑制作用,然后自由激活信号传导并最终通过GLI转录因子调节基因表达。 HH/GLI途径在胚胎和产后毛囊生长过程中具有良好的功能,它为上皮细胞提供了主要的增殖刺激,因为它们迅速扩展以构建成熟的Anagen毛囊。然而,从本质上讲,HH/Gli活性在静息肠卵泡中的一小部分细胞中的作用尚未知道,这是最近才发现的。另外,尚不清楚成熟的HH/GLI信号传导的持续HH/GLI信号传导的功能。我们建议使用几种互补的体内方法解决这两个问题,这将使我们能够在途径中以及在头发周期中的特定时间内阻止HH/GLI信号传导。我们还建议测试其他器官中HH/GLI靶标在毛囊生物学中的转录阻遏物BMI1的作用。这些研究的结果将填补我们对HH/GLI信号如何促进毛囊生物学的复杂调节的主要空白,并可能导致毛囊疾病发病机理的线索。在全球范围内,它们将提供对许多其他器官用于生长和再生使用的途径的基本见解,并且通常在癌症中放松管制。最后,由于目前正在进行临床试验中,由于有几种HH途径抑制剂,因此这些研究将及时,因为它们将更好地了解与患者使用这些药物有关的潜在毒性。 公共卫生相关性:毛囊和相关结构的异常是导致许多常见的皮肤疾病和脱发疾病。该赠款中的实验将增加我们对调节毛囊生长和发育的控制机制的理解。这些知识应导致与毛囊相关皮肤疾病的新治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDRZEJ A. DLUGOSZ其他文献

ANDRZEJ A. DLUGOSZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDRZEJ A. DLUGOSZ', 18)}}的其他基金

The Aging Cutaneous Microenvironment and Cancer Initiation
老化的皮肤微环境与癌症发生
  • 批准号:
    10490433
  • 财政年份:
    2021
  • 资助金额:
    $ 34.74万
  • 项目类别:
The Aging Cutaneous Microenvironment and Cancer Initiation
老化的皮肤微环境与癌症发生
  • 批准号:
    10659237
  • 财政年份:
    2021
  • 资助金额:
    $ 34.74万
  • 项目类别:
The Aging Cutaneous Microenvironment and Cancer Initiation
老化的皮肤微环境与癌症发生
  • 批准号:
    10292761
  • 财政年份:
    2021
  • 资助金额:
    $ 34.74万
  • 项目类别:
Cell fate decisions in Merkel cell carcinoma initiation and maintenance
默克尔细胞癌发生和维持的细胞命运决定
  • 批准号:
    9973721
  • 财政年份:
    2020
  • 资助金额:
    $ 34.74万
  • 项目类别:
Cell fate decisions in Merkel cell carcinoma initiation and maintenance
默克尔细胞癌发生和维持的细胞命运决定
  • 批准号:
    10330465
  • 财政年份:
    2020
  • 资助金额:
    $ 34.74万
  • 项目类别:
Cell fate decisions in Merkel cell carcinoma initiation and maintenance
默克尔细胞癌发生和维持的细胞命运决定
  • 批准号:
    10549793
  • 财政年份:
    2020
  • 资助金额:
    $ 34.74万
  • 项目类别:
Animal Modeling Core
动物建模核心
  • 批准号:
    10643966
  • 财政年份:
    2019
  • 资助金额:
    $ 34.74万
  • 项目类别:
Animal Modeling Core
动物建模核心
  • 批准号:
    10188436
  • 财政年份:
    2019
  • 资助金额:
    $ 34.74万
  • 项目类别:
Animal Modeling Core
动物建模核心
  • 批准号:
    10415108
  • 财政年份:
    2019
  • 资助金额:
    $ 34.74万
  • 项目类别:
Probing the role of aging in basal cell carcinoma development and treatment response
探讨衰老在基底细胞癌发展和治疗反应中的作用
  • 批准号:
    9203505
  • 财政年份:
    2016
  • 资助金额:
    $ 34.74万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

2023 Epithelial Differentiation and Keratinization GRC & GRS
2023 上皮分化和角化GRC
  • 批准号:
    10608540
  • 财政年份:
    2023
  • 资助金额:
    $ 34.74万
  • 项目类别:
Mechanisms of Smoothened Activation in Hedgehog Signaling
Hedgehog 信号传导平滑激活机制
  • 批准号:
    10365068
  • 财政年份:
    2022
  • 资助金额:
    $ 34.74万
  • 项目类别:
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention
用于口腔鳞癌化学预防的纳米颗粒释放口腔薄膜的配方、评估和 0 期试验
  • 批准号:
    10540811
  • 财政年份:
    2021
  • 资助金额:
    $ 34.74万
  • 项目类别:
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention
用于口腔鳞癌化学预防的纳米颗粒释放口腔薄膜的配方、评估和 0 期试验
  • 批准号:
    10359559
  • 财政年份:
    2021
  • 资助金额:
    $ 34.74万
  • 项目类别:
Understanding Patched1 protein and lipid interactions in cilia
了解纤毛中的 Patched1 蛋白和脂质相互作用
  • 批准号:
    10458525
  • 财政年份:
    2021
  • 资助金额:
    $ 34.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了